HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oxygen Biotherapeutics posts clinical results

This article was originally published in The Rose Sheet

Executive Summary

Marketer of Dermacyte skin-care line - which delivers high levels of oxygen to skin to detoxify cells and prevent collagen breakdown, the company says - announces results from eight-week study evaluating use of its Dermacyte Oxygen Concentrate in 36 women ages 39 to 63 with mild to moderate facial wrinkles. Durham, N.C.-based firm says 80% of participants experienced at least one grade of improvement on the Fitzpatrick Wrinkle Assessment Scale, which measures wrinkle depth and the breakdown of tissues that leads to reduced elasticity. According to Oxygen Biotherapeutics, 97% improved at least one grade, compared with baseline photos, on the Global Improvement Aesthetic Scale, and 84% reported a similar outcome based on self-perception of GIAS. "We are pleased that the findings of this study ... showed promising results for nearly all patients," says company's Chief Medical Officer Gerald Klein. Dermacyte Oxygen Concentrate is the first product in a broad and diverse cosmetics line," according to Oxygen Biotherapeutics, which over the long term is developing medical products for delivering oxygen in cases of traumatic brain injury, decompression sickness and topical wounds (1"The Rose Sheet" Nov. 2, 2009). The concentrate sells online for $84 along with company's recently launched Oxygenating Eye Complex, priced at $120

You may also be interested in...

Biotech Firm Launches Oxygen-Infusing Gel For Aging Skin

Biotechnology products marketer Oxygen Biotherapeutics is making its foray into the cosmetic realm with plans for a range of topical skin-care products that breathe new life into aging skin

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts